Is docetaxel-prednisone (DP) feasible in frail elderly (age 75 or older) patients with castration-resistant metastatic prostate cancer (CRMPC)? GERICO10-GETUG P03 trial: A trial from elderly and genitourinary oncology UNICANCER groups.
Loic Mourey
No relevant relationships to disclose
Emmanuel Sevin
No relevant relationships to disclose
Igor Latorzeff
No relevant relationships to disclose
Nadine Houede
No relevant relationships to disclose
Jérome Meunier
No relevant relationships to disclose
Frank Priou
No relevant relationships to disclose
Gwenaelle Gravis
No relevant relationships to disclose
Elisabeth Carola
No relevant relationships to disclose
Christine Orsini
No relevant relationships to disclose
Thomas Filleron
No relevant relationships to disclose